Results 11 to 20 of about 18,941 (217)

Inferior Vena Cava Filters [PDF]

Clinical and Applied Thrombosis/Hemostasis, 2013
Venous thromboembolism is common. Most pulmonary emboli arise as thromboses in the deep veins of the lower extremities and may result in serious complications. Inferior vena cava filters (IVCF) are intended to prevent the passage of deep vein thrombosis to the pulmonary arteries.
A. Nicolaides, J. Fareed, A. K. Kakkar, A. J. Comerota, S. Z. Goldhaber, R. Hull, K. Myers, M. Samama, J. Fletcher, E. Kalodiki, D. Bergqvist, J. Bonnar, J. A. Caprini, C. Carter, J. Conard, B. Eklof, I. Elalamy, G. Gerotziafas, G. Geroulakos, A. Giannoukas, I. Greer, M. Griffin, S. Kakkos, M. R. Lassen, G. D. O. Lowe, A. Markel, P. Prandoni, G. Raskob, A. C. Spyropoulos, A. G. Turpie, J. M. Walenga, D. Warwick   +31 more
  +12 more sources

Optimizing inferior vena cava filter design: A computational fluid dynamics study on strut configuration for enhanced hemodynamic performance and thrombosis reduction [PDF]

Heliyon
Background and objective: Inferior vena cava filters have been shown to be effective in preventing deep vein thrombosis and its secondary complication, pulmonary embolism, thereby reducing the high mortality rate. Although inferior vena cava filters have
Byeong-Jun Kim, Chiseung Lee
doaj   +2 more sources

Vena cava filters in cancer patients: experience with 50 patients Filtros de veia cava inferior em pacientes com câncer: experiência em 50 casos [PDF]

Clinics, 2005
OBJECTIVE: To study the immediate and late results obtained from the implantation of vena cava filters in cancer patients with deep vein thrombosis concomitant with neoplasia.
Antonio Eduardo Zerati, Nelson Wolosker, Guilherme Yazbek, Marcel Langer, Kenji Nishinari   +4 more
doaj   +3 more sources

Inferior Vena Cava Filters [PDF]

World Journal of Surgery, 2006
Venous thromboembolism (VTE) remains a common disease with significant clinical impact upon our patients. Diagnostic challenges occur because of the nonspecific nature of the presenting symptoms. The advent of multidetector computed tomography, methods to stratify patients into VTE risks (low, intermediate, high) along with serological assays (D-dimers)
Sunil S. Rayan, Thomas F. Dodson
  +8 more sources

Vena Cava Filter Misplacement: A Killer Traveler

Brazilian Journal of Cardiovascular Surgery, 2022
Inferior vena cava filter embolization is not uncommon and can reach 11.8%. However, device migration to the heart is not frequent and occurs in cases after inferior vena cava filter fracture.
Leonardo Rufino Garcia, André Monti Garzesi, Antonio Sérgio Martins, Marcone Lima Sobreira, Flavio de Souza Brito, Marcello Laneza Felicio   +5 more
doaj   +1 more source

Inferior vena cava filters in pregnancy: Safe or sorry?

Frontiers in Cardiovascular Medicine, 2022
BackgroundPotential hazards of vena cava filters include migration, tilt, perforation, fracture, and in-filter thrombosis. Due to physiological changes during pregnancy, the incidence of these complications might be different in pregnant women.AimTo ...
Ingrid M. Bistervels, Ingrid M. Bistervels, Andrea Buchmüller, Andrea Buchmüller, Bernard Tardy   +4 more
doaj   +1 more source

Uncomplicated percutaneous IVC filter removal following implantation time of 6033 days

Radiology Case Reports, 2020
Most patients have a time limited indication for inferior vena cava filtration. When the indication has expired, a retrievable inferior vena cava filter should be removed percutaneously, unless the risks of retrieval outweigh the benefits.
Hans Michell, MD, Gregory P. Johnston, MD, Christopher S. Morris, MD   +2 more
doaj   +1 more source

Inferior vena cava filters

Canadian Medical Association Journal, 2015
Under fluoroscopic guidance, IVC filters are placed percutaneously via the jugular or femoral vein. Current guidelines recommend use in patients with known venous thromboembolism who have an absolute contraindication to anticoagulant therapy (e.g., patients with hemorrhagic stroke or ...
Sean A, Kennedy, Mark O, Baerlocher
openaire   +3 more sources

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis

Hepatology, EarlyView., 2022
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Abstract Background and Aims Nucleotide‐binding oligomerization domain‐like receptor‐family pyrin domain‐containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis.
Jana Knorr, Benedikt Kaufmann, Maria Eugenia Inzaugarat, Theresa Maria Holtmann, Lukas Geisler, Jana Hundertmark, Marlene Sophia Kohlhepp, Laela M. Boosheri, Daisy R. Chilin‐Fuentes, Amanda Birmingham, Kathleen M. Fisch, Joel D. Schilling, Sven H. Loosen, Christian Trautwein, Christoph Roderburg, Münevver Demir, Frank Tacke, Hal M. Hoffman, Ariel E. Feldstein, Alexander Wree   +19 more
wiley   +1 more source

Case report: Endoluminal removal of a retrievable conical inferior vena cava filter with a ruptured retraction hook attached to the wall

Frontiers in Surgery, 2022
We report the case of a patient who underwent endovascular retrieval of a conical inferior vena cava (IVC) filter with a ruptured retraction hook that was attached to the IVC wall.
Xuan Tian, Jianlong Liu, Jinyong Li, Xiao Liu   +3 more
doaj   +1 more source